Literature DB >> 31433957

Effect of Nusinersen on Respiratory Muscle Function in Different Subtypes of Type 1 Spinal Muscular Atrophy.

Antonella LoMauro1, Chiara Mastella2, Katia Alberti2, Riccardo Masson3, Andrea Aliverti1, Giovanni Baranello3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31433957     DOI： 10.1164/rccm.201906-1175LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  8 in total

Review 1.  Spinal muscular atrophy - insights and challenges in the treatment era.

Authors:  Eugenio Mercuri; Maria Carmela Pera; Mariacristina Scoto; Richard Finkel; Francesco Muntoni
Journal:  Nat Rev Neurol       Date:  2020-10-14       Impact factor: 42.937

Review 2.  Thoracic insufficiency syndrome: Approaches to assessment and management.

Authors:  Katharine Tsukahara; Oscar Henry Mayer
Journal:  Paediatr Respir Rev       Date:  2022-03-07       Impact factor: 5.526

3.  Tailoring NIV by dynamic laryngoscopy in a child with spinal muscular atrophy type I.

Authors:  Maria Vollsæter; Anett Skjoldmo; Ola Røksund; Magnus Hilland; Tiina Andersen
Journal:  Clin Case Rep       Date:  2021-02-12

4.  RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study Design.

Authors:  Richard S Finkel; John W Day; Darryl C De Vivo; Janbernd Kirschner; Eugenio Mercuri; Francesco Muntoni; Perry B Shieh; Eduardo Tizzano; Isabelle Desguerre; Susana Quijano-Roy; Kayoko Saito; Marcus Droege; Omar Dabbous; Farid Khan; Lydie Renault; Frederick A Anderson; Laurent Servais
Journal:  J Neuromuscul Dis       Date:  2020

5.  Nusinersen: A Review in 5q Spinal Muscular Atrophy.

Authors:  Sheridan M Hoy
Journal:  CNS Drugs       Date:  2021-11-30       Impact factor: 5.749

6.  Combination Therapy with Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type I.

Authors:  Andrada Mirea; Elena-Silvia Shelby; Mihaela Axente; Mihaela Badina; Liliana Padure; Madalina Leanca; Vlad Dima; Corina Sporea
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

Review 7.  Changes in Ventilatory Support Requirements of Spinal Muscular Atrophy (SMA) Patients Post Gene-Based Therapies.

Authors:  Panagiota Panagiotou; Christina Kanaka-Gantenbein; Athanasios G Kaditis
Journal:  Children (Basel)       Date:  2022-08-11

8.  Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular Atrophy.

Authors:  Giovanni Baranello; Ksenija Gorni; Monica Daigl; Anna Kotzeva; Rachel Evans; Neil Hawkins; David A Scott; Anadi Mahajan; Francesco Muntoni; Laurent Servais
Journal:  Clin Pharmacol Ther       Date:  2021-06-05       Impact factor: 6.903
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.